Abstract
Preparative reversed phase high pressure liquid chromatography (prep-RP-HPLC) coupled with photodiode array (PDA) and evaporative light scattering (ELSD) detectors was employed to isolate picrosides present in Picrorhiza kurroa Royle ex Benth. A binary gradient method (water and acetonitrile) was optimized on Water Spherisorb S10 ODS2 20 mm × 250 mm Semiprep Column with a 20 mL/min flow rate at ambient temperature with linear binary gradient conditions; at 0 min 15 % acetonitrile hold for 15 min; 15 to 22 % acetonitrile in next 2 min, hold for 13 min; 22 to 15 % acetonitrile in 5 min hold for 5 min to equilibrate column for next injection. The picroside-I and picroside-II fractions were 98.6 and 99.7 % pure with 13.9 mg and 9.8 mg yield per 200 mg of crude extract, respectively from mature dry rhizomes. Structures of isolated iridoids were confirmed with UV scan, 1H-NMR and direct infusion ESI-Q-TOF-MS/MS data.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Picrorhiza kurroa Royle ex Benth (Family: Scrophulariaceae) is an endangered herb of the North-Western Himalayan regions of India grown at altitudes of 3000–4300 m (Sood and Chauhan 2010). The herb is of a high medicinal value and used in various formulations such as Picroliv, Katuki, Arogya, Livomap and Kutaki (Bhandari et al. 2009). The plants is primarily used for its hepatoprotective effect (Saraswat et al. 1999) and also possess other pharmacological activities like anti-tumour and anti-carcinogenic (Joy et al. 2000), antioxidant (Gangola et al. 2013; Rajkumar et al. 2011; Tiwari et al. 2012), Immunomodulatory (Gupta et al. 2006), anti-allergic (Baruah et al. 1998),anti-asthmatic, scavengers of superoxide(Chander et al. 1992), antiviral (Kapadia et al. 1996; Medasani and Divi 2011) and anti-diabetic (Joy and Kuttan 1999). These medicinal activities have been implicated due to the presence of two major iridoids, picroside-I (P-I) and picroside-II (P-II) (Fig. 1) (Ansari et al. 1991). The plant is mainly used either as a raw powder or as alcoholic extracts comprising both compounds, P-I and P-II which do have individual activities such as P-I is active against breast cancer, has stimulatory effect on P-glycoprotein ATPase activity (Najar et al. 2010; Rathee et al. 2013) and P-II is effective in cerebral ischemia, hepatocyte apoptosis liver fibrosis and anti-lipid peroxidation (Gao 2005a; Gao and Zhou 2005b; Guo et al. 2010; Guo et al. 2011; Lee et al. 2008; Lee and Ku 2008). Acylated analogs of picroside-II have been tested for immune-adjuvant activity in the presence of weak antigen ovalbumin (Chen et al. 2011; Kumar et al. 2010). Hence it is important to isolate these compounds from the plant to develop new formulations that are specific in their pharmacological action. Previously these compounds were isolated with counter-current chromatography from Picrorhiza scrophulariiflora but the method is tedious, time consuming and uses large amount of high quantity of solvents (Chen et al. 2011). Therefore, optimization of a rapid, time and cost effective method for isolation and purification of P-I and P-II is required.
Experimental
Instruments used
The Waters Preparative HPLC (2545 Binary Gradient Module, SFO, 2998 Photodiode Array Detector, 2424 Evaporative Light Scattering Detector and 2767 Sample Manager and fraction collector) controlled with MassLynx 4.0 was employed for isolation of P-I and P-II and Waters HPLC (515 pump, 717plus Autosampler, 2996 Photodiode Array Detector) controlled with Empower was used for purity analysis of fractions obtained. Waters Micromass Q-TOF MS controlled by MassLynx 4.0 and Bruker compact® Q-ToF were used for molecular mass determination and mass fragmentation. Heidolph 2 G3 Rotary evaporator was used for concentrating the crude extract and evaporation of fractions.
Chemicals and reagents
Picroside-I and picroside-II standards were procured from ChromaDex, India. Methanol and acetonitrile solvents (HPLC Grade, Merck, India) were used for method optimization, extraction and sample preparation. Trifluoroacetic acid and acetic acid were procured from Merck, India. Milli Q Plus ultra-pure water was used in all the experiments (Millipore, Milford, MA).
Sample
P. kurroa tissue samples were collected from plants grown in nursery (Sairopa, Himachal Pradesh, 4500 m altitude, 31°38′ -31°54′ N and 77°20′-77°45′ E) and a voucher sample was submitted to HFRI (Himalayan Forest Research Institute, Shimla, HP, India) with Herbarium Acc. No. 0670.
LC-qtof-HRMS/MS method
All analyses were acquired using internal calibration before starting each LCMS run from 0.0 to 0.7 min of each chromatogram. The internal calibration was performed using a syringe pump (kd Scientific, Holliston, MA USA.) connected to interface with divert valve, passing a solution of sodium formate cluster containing 5 mM sodium hydroxide and 2 % formic acid in water: isopropyl alcohol 1:1 (v/v). A calibration curve based on numerous cluster masses, each differing by 68 Da (NaCHO2) was plotted. It compensates the temperature drift in the TOF with each run and provides accurate mass values for each LCMS run. LC-HRMS analysis was carried out on a reversed phase Waters Spherisorb® 5μmm ODS2 (250 mm × 4.6 mm i.d.) reverse phase column with 0.8 mL/min flow rate at 35 °C column temperature. The mobile phase was 0.2 % formic acid in water and mixed with acetonitrile in 80:20 ratios. Bruker compact® Q-ToF was operated in negative ionization (NI) mode for 10 min during LC run at 4500 capillary voltage, −500 V end plate offset, 2000 V charging voltage, nebulizer at 1.5 Bar, dry heater at 200 °C, dry gas at 7.0 L/min, 10.0 source collision energy and mass scan range of m/z 80 to 1300 for MS and autoMS2 with collision energy 30 up to m/z 1000.
Preparation of crude extract
Leaves, roots and rhizomes were collected and stored in −20 °C till utilized for extraction to prevent degradation of metabolites. 2 g of sample was powdered finely in liquid nitrogen with the help of a pestle mortar. The powder was transferred immediately to a 500 mL beaker; 100 mL of methanol was added and sonicated for 20 min. The mixture was shaken periodically to increase the extraction efficiency. The mixture was centrifuged at 3000 rpm to settle down the plant material. Solvent was decanted and again extracted with 100 mL of methanol; this step was repeated for 2 times. All three fractions were mixed, filtered with whatman filter paper and concentrated under reduced pressure at 30 °C up to 1/20th of the original volume. The solution was stored at 4 °C until used. The extracted sample was filtered through 0.45 μm PVDF filter (Millipore) before injecting HPLC column.
Preparative RP-HPLC method
A binary gradient method was optimized after several isocratic and gradient trials of different compositions of mobile phase, volatile buffers trifluoroacetic acid and acetic acid but the picrosides were not stable in acidic medium hence water was used as mobile phase with acetonitrile and methanol in different compositions. For getting sharp peaks and desired resolution, methanol was replaced with acetonitrile. MiliQ water was used as a mobile phase A, the water was degassed by sonication for 5 min in ultra-sonication bath by applying vacuum on water. The filtered and degassed acetonitrile was used as mobile phase B. For achieving separation, Water Spherisorb S10 ODS2 20 × 250 mm Semiprep Column (SN. 0125111571KK00) was used as Prep HPLC Column with a 20 mL/min flow rate at ambient temperature with linear binary gradient conditions; at 0 min 15 % B hold for 15 min; 15 % to 22 % B in next 2 min, hold for 13 min; 22 to 15 % B in 5 min hold for 5 min to equilibrate column for next injection. Injector was set at 900 μL with partial loop fill with PDA detection from 200 to 400 nm UVscan and the fraction collector was set at the retention time and UV spectra of peaks obtained from chromatogram matched with that of peaks of picroside-I and picroside-II. The ELS detector was also used to see the mass ratio of these two compounds which was found to be 1.7 (Fig. 2). ELS detector conditions were optimized at 40 psi gas pressure, nebulizer heating at 90 % and drift tube temperature 90 ± 25 °C with timed event on gain at 0 min gain on 1, 3 min gain change to 100 which remained up to 36 min, again changed to 1 at 36.5 min. The time based collection of the peaks were done, fractions at 20.2–20.8 min interval for picroside-II and fraction at 25.1–25.7 min interval for picroside-I were collected at room temperature and stored at −20 °C for further processing. The fractions stored at −20 °C were evaporated under reduced pressure at 30 °C to evaporate organic part of fractions. The concentrated aqueous fractions were kept at −80 °C for 4 h to freeze. The frozen fractions were lyophilized to get solid and purified picroside-I and picroside-II.
HPLC analysis for purity and identification of fractions collected
HPLC analysis was carried out on a reversed phase Waters Spherisorb® 5μmm ODS2 (250 × 4.6 mm i.d.) reverse phase column with 1 mL/min flow rate at ambient temperature. The mobile phase A was 0.05 % trifluoroacetic acid in HPLC grade water and mobile phase B were acetonitrile/methanol in 1:1 ratio. The mobile phase A and mobile phase B were used in 70:30 ratio as isocratic mode with a 1 mL/min flow rate. A 20 μL sample was injected to column maintained at 30 °C temperature and data were acquired at 280 nm UV wavelength after matching spectra and retention time with authentic sample (Pandit et al. 2013). MS and MS2 Micromass Q-TOF was operated in negative ionization (NI) mode at 2731.0 capillary voltage, 30.0 sample cone voltage, 2.0 extraction cone voltage, 300 °C desolvation temperature, 100 °C source temperature, 7.0 collision energy and mass scan range of m/z 100 to 1000 for MS and m/z 60 to 600 for MS2.
Results and discussion
The P-I and P-II were collectively quantified in crude methanolic extract and analysed by RP-HPLC and LC-MS to check the quality of sample (Fig. 3a). High picrosides content samples were selected and extracted with methanol. The buffers used in the prep-RP-HPLC should be volatile so that in rotary evaporator and lyophilization those can be removed easily, therefore, we had a limited choice of buffers such as ammonium salts (carbonate, bicarbonate, formate and acetate etc.) and acids like formic acid, acetic acid and trifluoroacetic acid (TFA). Methanolic extract of Picrorhiza kurroa was analyzed by HPLC and a preliminary method was prepared after several isocratic and gradient trials with formic acid, acetic acid and trifluoroacetic acid. An isocratic method at 1 mL/min flow rate containing water/acetonitrile/TFA (70:30:0.05 %) for 30 min was finalized for short run time and better resolution. The optimized method was then transferred to the prep-RP-HPLC using volume and mass loading formulas with slight modification in flow. This gave a better chromatogram but on increasing the injection loadings, the peaks merged thus giving less purity of compounds. However, the isolated fraction of P-I was degraded, giving less pure fractions whereas the fractions of P-II were stable. It was further investigated and found that P-I was acid sensitive and degrades under mild acidic conditions whereas P-II was stable. Therefore the TFA was removed from the mobile phase and again method was optimized. After removing TFA from mobile phase the peak was broad and gave a low resolution. Therefore, acetonitrile concentration was decreased to 15 from 30 % which gave a long run time and broad peaks. The method was changed to gradient elution program which started from 15 % acetonitrile and went up to 22 % linearly. The gradient elution program gave better peak shape and required resolution with a short run time (Fig. 4). The fraction collector was set as time based from time 20.2 to 20.8 min for P-II and 25.1 to 25.7 min for P-I. The purity of fractions were analyzed by HPLC and found to be highly pure and identified by retention time (Fig. 3b, c) with reference standard and MS2 spectra by CID. The P-I pseudo molecular [M-H]− ion i.e. m/z 491 gave daughter ions in MS2 spectra at m/z 199 [M-H-292]− by the loss of cinnamic acid and glucose moiety, m/z 147 and m/z 103 ions showed the presence of cinnamic acid. Daughter ion at m/z 169 [M-H-292-CH2OH] - was due to the loss of CH2OH group from m/z 199 ion. The MS2 of mass m/z 511 which corresponds to P-II gave daughter ions at m/z 167 and m/z 123 for vanilic acid, m/z 349 due to aglycone moiety [M-H-162]−.
Structure identification
The chemical structures of the peaks in Fig. 4 were identified according to their HR-MS and 1H-NMR data. (Supplementary data).
Peak 1: High resolution Negative electrospray ionization (HR-ESI-Q-TOF) MS, m/z 511.1463 (calc. 511.1457) [M- H]-. 1H-NMR (400 MHz, DMSO-d6) δ ppm 2.59 (m, 1H, 9-H) 2.65 (d, J = 8.44 Hz, 1H, 5-H) 3.25–3.66 (m, 4H, 3′-6′-H) 3.73 (d, J = 8.27 Hz,1H, 7-H) 3.78–3.88(m, 2H, 14′-H) 3.91(s, 3H, 13′-H) 4.07(d, J = 13.57 Hz, 1H, 10-H) 4.78(d, J = 7.70 Hz, 1H, 10-H) 4.89–5.03(m, 1H, 1′-H) 5.03–5.18(m, 2H, 1-H, 4-H) 6.34(m, 1H, 6-H) 6.90(d, J = 8.07 Hz, 1H, 3-H) 7.51(d, 1H, 11′-H) 7.53–7.62(d, 1H, 12′-H)7.78(s, 1H, 8′-H). The obtained product was identified as P-II.
Peak 2: High resolution Negative electrospray ionization (HR-ESI-Q-TOF) MS, m/z 491.1556 (calc. 491.1558) [M- H]-. 1H-NMR (400 MHz, DMSO-d6) δ ppm 2.17–2.30 (dd, J = 4.22, 1.65 Hz, 1H, 9-H) 2.54 (dd, J = 9.72, 7.89 Hz, 1H, 5-H) 3.25–3.58 (m, 4H, 3′-6′-H) 3.80 (d, J = 8.07 Hz,1H, 7-H) 4.10 (d, J = 13.20 Hz,1H, 10-H) 4.40 (dd, J = 11.92,5.32 Hz, 1H, 6-H) 4.45–4.57(d, J = 13.20 Hz,1H, 10-H) 4.78(d, J = 8.07 Hz,1H, 7′-H) 4.84(d, J = 9.90 Hz, 1H, 7′-H) 4.99–5.11(m, 1H, 1′-H) 6.19–6.34 (m, 2H, 1-H, 4-H) 6.48(d, J = 15.77 Hz, 1H, 3-H) 7.27–7.47(m, 4H, 12′-14′-H, 7′-H) 7.57(dd, J = 6.60, 2.93 Hz, 2H, 11′-H, 15′-H) 7.66 (d, J = 15.77 Hz,1H, 9′-H). The obtained product was identified as P-I.
Two main bioactive iridoids (picroside-I and picroside-II) from Picrorhiza kurroa Royle ex Benth were successfully isolated and purified with prep-RP-HPLC using binary gradient water and acetonitrile. From 200 mg of crude methanolic extract 13.9 P-I and 9.8 mg P-II was isolated with purities of 98.6 and 99.7 %, respectively in one step separation.
Abbreviations
- ELSD:
-
Evaporative Light Scattering Detector
- P-I:
-
Picroside-I
- P-II:
-
Picroside-II
- Q-TOF:
-
Quadrupole-time of flight
- ESI:
-
Electrospray ionization
- NI:
-
Negative ionization
- LCMS:
-
Liquid chromatography–mass spectrometry
- PVDF:
-
Polyvinylidene Fluoride
- MS2 :
-
Tandem mass spectrometry
- CID:
-
Collision induced dissociation
- RT:
-
Retention time
References
Ansari RA, Tripathi SC, Patnaik GK, Dhawan BN (1991) Antihepatotoxic properties of picroliv: an active fraction from rhizomes of Picrorhiza kurrooa. J Ethnopharmacol 34:61–68. doi:10.1016/0378-8741(91)90189-k
Baruah CC, Gupta PP, Nath A, Patnaik LG, Dhawan BN (1998) Anti-allergic and anti-anaphylactic activity of picroliv–a standardised iridoid glycoside fraction of picrorhiza kurroa. Pharmacol Res : Off J Italian Pharmacol Soc 38:487–492. doi:10.1006/phrs.1998.0397
Bhandari P, Kumar N, Singh B, Gupta A, Kaul V, Ahuja P (2009) Stability-indicating LC–PDA method for determination of picrosides in hepatoprotective Indian herbal preparations of Picrorhiza kurroa. Chromatographia 69:221–227. doi:10.1365/s10337-008-0889-7
Chander R, Kapoor NK, Dhawan BN (1992) Picroliv, picroside-I and kutkoside from Picrorhiza kurrooa are scavengers of superoxide anions. Biochem Pharmacol 44:180–183. doi:10.1016/0006-2952(92)90054-m
Chen Z, Wu J, Shen W, Liu P, Cao Y, Lu Y (2011) Counter-current chromatographic method for preparative scale isolation of picrosides from traditional medicine picrorhiza scrophulariiflora. J Sep Sci 34:1910–1916. doi:10.1002/jssc.201100025
Gangola M, Parkash J, Ahuja P, Dutt S (2013) Components of antioxidant system of Picrorhiza kurrooa exhibit different spatio-temporal behavior Mol Biol Rep:1-11 doi:10.1007/s11033-013-2772-3
Gao H, Zhou YW (2005a) Anti-lipid peroxidation and protection of liver mitochondria against injuries by picroside ii World J Gastroenterol: WJG 11:3671–3674
Gao H, Zhou YW (2005b) Inhibitory effect of picroside ii on hepatocyte apoptosis acta. Pharmacol Sin 26:729–736. doi:10.1111/j.1745-7254.2005.00729.x
Guo Y, Xu X, Li Q, Li Z, Du F (2010) Anti-inflammation effects of picroside 2 in cerebral ischemic injury Rats. Behav Brain Funct 6:43. doi:10.1186/1744-9081-6-43
Guo YL, Shen W, Du F (2011) [Effect of picroside II on expressions of TLR4 and NFkappaB in rats with cerebral ischemia reperfusion injury] zhongguo zhong xi yi jie he za zhi zhongguo zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and western medicine/zhongguo zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu Yuan zhu ban 31:58–61
Gupta A et al. (2006) Immunomodulatory activity of biopolymeric fraction RLJ-NE-205 from Picrorhiza kurroa. Int Immunopharmacol 6:1543–1549. doi:10.1016/j.intimp.2006.05.002
Joy KL, Kuttan R (1999) Anti-diabetic activity of Picrorrhiza kurroa extract. J Ethnopharmacol 67:143–148. doi:10.1016/s0378-8741(98)00243-8
Joy KL, Rajeshkumar NV, Kuttan G, Kuttan R (2000) Effect of Picrorrhiza kurroa extract on transplanted tumours and chemical carcinogenesis in mice. J Ethnopharmacol 71:261–266. doi:10.1016/s0378-8741(00)00168-9
Kapadia GJ, Sharma SC, Tokuda H, Nishino H, Ueda S (1996) Inhibitory effect of iridoids on epstein-barr virus activation by a short-term in vitro assay for anti-tumor promoters. Cancer Lett 102:223–226
Kumar HM et al. (2010) Development of novel lipidated analogs of picroside as vaccine adjuvants: acylated analogs of picroside-II elicit strong Th1 and Th2 response to ovalbumin in mice. Vaccine 28:8327–8337. doi:10.1016/j.vaccine.2010.07.062
Lee HS, Ku SK (2008) Effect of picrorrhiza rhizoma extracts on early diabetic nephropathy in streptozotocin-induced diabetic rats. J Med Food 11:294–301. doi:10.1089/jmf.2007.578
Lee HS, Kim HH, Ku SK (2008) hepatoprotective effects of artemisiae capillaris herba and picrorrhiza rhizoma combinations on carbon tetrachloride-induced subacute liver damage in rats Nutr Res 28:270–277 doi:10.1016/j.nutres.2008.02.001
Medasani M, Divi SB (2011) Picrorhiza kurroa extract for prevention, elimination and treatment of rna viruses and infection or diseases caused by the same in humans, animals and in biotech industry. Patent WO2011027364 A2, March 10, 2011
Najar IA, Sachin BS, Sharma SC, Satti NK, Suri KA, Johri RK (2010) Modulation of p-glycoprotein atpase activity by some phytoconstituents. Phytother Res 24:454–458. doi:10.1002/ptr.2951
Pandit S, Shitiz K, Sood H, Naik PK, Chauhan RS (2013) Expression pattern of fifteen genes of non-mevalonate (mep) and mevalonate (mva) pathways in different tissues of endangered medicinal herb picrorhiza kurroa with respect to picrosides content. Mol Biol Rep 40:1053–1063. doi:10.1007/s11033-012-2147-1
Rajkumar V, Guha G, Kumar RA (2011) Antioxidant and anti-neoplastic activities of picrorhiza kurroa extracts food and chemical toxicology : an international J Published British ind Biol Res Assoc 49:363–369. doi:10.1016/j.fct.2010.11.009
Rathee D, Thanki M, Bhuva S, Anandjiwala S, Agrawal R (2013) Iridoid glycosides-kutkin, picroside I, and kutkoside from picrorrhiza kurroa benth inhibits the invasion and migration of MCF-7 breast cancer cells through the down regulation of matrix metalloproteinases. Arab J Chem 6:49–58. doi:10.1016/j.arabjc.2011.01.011
Saraswat B, Visen PKS, Patnaik GK, Dhawan BN (1999) Ex vivo and in vivo investigations of picroliv from Picrorhiza kurroa in an alcohol intoxication model in rats. J Ethnopharmacol 66:263–269. doi:10.1016/s0378-8741(99)00007-0
Sood H, Chauhan R (2010) Biosynthesis and accumulation of a medicinal compound, picroside-i, in cultures of Picrorhiza kurroa Royle ex Benth. Plant Cell Tissue Organ Cult 100:113–117. doi:10.1007/s11240-009-9618-7
Tiwari SS, Pandey MM, Srivastava S, Rawat AK (2012) TLC densitometric quantification of picrosides (picroside-I and picroside-II) in picrorhiza kurroa and its substitute picrorhiza scrophulariiflora and their antioxidant studies. Biomed Chromatogr : BMC 26:61–68. doi:10.1002/bmc.1626
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary material
Supplementary Fig. 1
(GIF 42 kb)
Supplementary Fig. 2
(GIF 41 kb)
Supplementary Fig. 3
(GIF 19 kb)
Supplementary Fig. 4
(GIF 16 kb)
Supplementary Fig. 5
(GIF 24 kb)
Supplementary Fig. 6
(GIF 22 kb)
Supplementary Fig. 7
(GIF 38 kb)
Rights and permissions
About this article
Cite this article
Kumar, V., Sood, H. & Chauhan, R.S. Optimization of a preparative RP-HPLC method for isolation and purification of picrosides in Picrorhiza kurroa . J. Plant Biochem. Biotechnol. 25, 208–214 (2016). https://doi.org/10.1007/s13562-015-0327-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13562-015-0327-5